This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Prestige Brands Holdings, Inc. To Release Fiscal 2013 First Quarter Earnings On August 7th

Prestige Brands Holdings, Inc. (NYSE: PBH) today announced that it will issue its fiscal 2013 first quarter earnings release on Tuesday, August 7, 2012 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. EST.

To access the call, listeners calling from within North America may dial 800-901-5218 about 15 minutes prior to the start of the call. Those wishing to access the call from outside North America should dial 617-786-4511. The conference pass code is “prestige”. The Company will provide a live internet web cast as well as an archived replay, which can be accessed from the Investor Relations page of http://prestigebrands.com.

Telephonic replays will be available for two weeks following completion of the live call and can be accessed at 888-286-8010 within North America, and at 617-801-6888 from outside North America. The pass code is 48717915.

Prestige Brands markets and distributes brand name over-the-counter healthcare and household products throughout the United States, Canada and certain international markets. Core brands include Chloraseptic ® sore throat treatments, Compound W ® wart treatments, Clear Eyes ® eye care products, Little Remedies ® and PediaCare ® pediatric over-the-counter healthcare products, The Doctor’s ® NightGuard® dental protector, Efferdent ® denture care products, Luden’s ® throat drops, Dramamine ® motion sickness treatment, BC ® and Goody’s ® headache remedies, Beano ® gas prevention, Debrox ® earwax remover, and Gaviscon ® antacid.



Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,162.99 +121.45 0.67%
S&P 500 2,123.48 +19.28 0.92%
NASDAQ 5,106.5930 +73.8420 1.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs